China Biologic Renews GMP Certification Under Stiffer SFDA GMP Rules
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI- China Biologic Products has renewed its GMP certification for its production facility in Taian City in compliance with China State FDA's new, strict GMP standards, which took effect in January
You may also be interested in...
China Biologic Starts Selling Human Immunoglobulin To Neighboring India, Scans Globe For New Markets
BEIJING - China Biologic Products has signed a unique deal to supply India with plasma-based biopharmaceuticals, and is scanning the global market for other potential importers, according to company executives
China Biologic Starts Selling Human Immunoglobulin To Neighboring India, Scans Globe For New Markets
BEIJING - China Biologic Products has signed a unique deal to supply India with plasma-based biopharmaceuticals, and is scanning the global market for other potential importers, according to company executives
China Biologic Opens New Plasma Collection Station As China’s Blood Product Reforms Have Closed Doors For Many Competitors
SHANGHAI - China Biologic Products began operations at its new plasma collection station in Qihe County, Shandong Province, the company announced July 9, increasing its annual supply of plasma from 60 to 80 metric tons to 100 metric tons